Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction
Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction
复制标题
DOI:
10.1016/j.ijcard.2010.08.015
复制
发表时间:
2011-12-15
影响因子:
3.5
通讯作者:
Baldus, Stephan
中科院分区:
文献类型:
--
作者:
Rudolph, Volker;Goldmann, Britta U.;Baldus, Stephan
Background: Besides its well-established role in atherosclerosis, myeloperoxidase (MPO) has gained attention as a prognostic indicator in cardiovascular disease. Previous studies assessed MPO retrospectively and at a single time point. The current study aimed to evaluate the prognostic information of MPO prospectively and in consecutive measurements in patients presenting with chest pain.Methods: MPO plasma levels were determined in 274 consecutive chest pain patients admitted to the emergency room.Results: A total of 100 patients (36.5%) were finally diagnosed for acute myocardial infarction (AMI). Patients with AMI had significantly higher MPO levels than patients without AMI. Importantly, MPO levels were elevated in patients finally diagnosed for AMI even when troponin I (TNI) was negative (cutoff: 0.032 ng/ml). Overall, MPO yielded a negative predictive value (NPV) of 85.5% (95% confidence interval (CI): 82.6-88.4) and a sensitivity for diagnosing AMI of 80.0% (95% CI: 75.8-84.2) compared to a NPV of 91.7% (95% CI: 89.5-94.0) and a sensitivity of 85.9% (95% CI: 82.3-89.5) for TNI. For patients with a symptom onset of